Related Experiment Video
Updated: Jan 28, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Comparison of Morphine- and Hydromorphone-Containing Patient-Controlled Epidural Analgesia Solutions in Pediatric
Insights
Morphine-based patient-controlled epidural analgesia (PCEA) may offer better postoperative pain control in children than hydromorphone. This study found morphine provided superior pain management for pediatric patients after surgery.
Area of Science:
- Pediatric Anesthesiology
- Pain Management
- Pharmacology
Background:
- Patient-controlled epidural analgesia (PCEA) is a safe and effective method for managing pediatric postoperative pain.
- The optimal opioid for PCEA in children is not well-established, with morphine, hydromorphone, and fentanyl being common choices.
- Comparing the effectiveness of different opioids in PCEA regimens is challenging due to study heterogeneity.
Purpose of the Study:
- To compare postoperative pain scores in pediatric patients receiving PCEA solutions containing either ropivicaine plus morphine or ropivicaine plus hydromorphone.
- To evaluate the effectiveness of morphine versus hydromorphone in PCEA for managing acute pain in children.
Main Methods:
- Retrospective chart review of pediatric patients (ages 5-17) who received morphine- or hydromorphone-containing PCEA postoperatively.
- Analysis of maximum pain scores during the first 48 hours after surgery.
- Primary outcome: incidence of maximum pain scores ≤4 on postoperative days 0 and 1.
Main Results:
- Patients receiving morphine-PCEA had a significantly higher incidence of maximal pain scores ≤4 compared to those on hydromorphone-PCEA (p=0.03).
- Ropivicaine dosage did not significantly impact pain scores and showed no statistical difference between opioid groups.
- Pediatric patients effectively utilized PCEA on-demand doses, with higher pain scores correlating with increased demand (p≤0.002).
- No serious adverse events were reported.
Conclusions:
- Morphine-containing PCEA may provide superior postoperative pain control in pediatric patients compared to hydromorphone.
- Limitations include the heterogeneous nature of surgical procedures and a small sample size, which affect generalizability.
Objective:
The use of patient-controlled epidural analgesia (PCEA) in pediatric patients has been shown to be safe and effective in managing postoperative pain in children. However, the optimal opioid to use in the epidural regimen remains undetermined. Morphine, hydromorphone, and fentanyl have been the agents most often used, but comparison of effectiveness across studies is difficult. The goal of this study was to compare postoperative pain scores in patients receiving PCEA solutions that contained either ropivicaine plus morphine or ropivicaine plus hydromorphone.
Methods:
Retrospective chart review was used at a single center to identify pediatric patients between the ages of 5 and 17 years who used a morphine- or hydromorphone-containing PCEA solution postoperatively during an 18-month period. Maximum pain scores were recorded during 2 consecutive 24-hour periods postoperatively. The primary outcome was the number of patients who had a maximum pain score of ≤4 on postoperative day zero and postoperative day 1.
Results:
Forty-six patients met the inclusion criteria and were analyzed. Patients prescribed morphine-containing PCEAs had a significantly higher incidence of maximal pain scores ≤4 in the 48 hours immediately after surgery compared with those patients prescribed hydromorphone-containing PCEAs (p = 0.03). Ropivicaine dosing in the epidural solution did not have a significant effect on pain scores and was not statistically different between opioid groups. Pediatric patients were able to effectively use the PCEA on-demand dose, with patients having pain scores >4 demanding significantly more on-demand doses from the PCEA than those patients with pain scores ≤4 (p ≤ 0.002). No serious adverse events were reported.
Conclusions:
Morphine-containing PCEAs may have an advantage in controlling postoperative pain in pediatric patients compared with hydromorphone-containing PCEAs. However, the heterogeneous nature of the procedures performed and the small sample size limit the generalizability of this study.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Patient-centered Care
Drug Dosing: Obese Patients

